An international study led by UBC Okanagan researchers suggests repeated use of small doses of psychedelics such as psilocybin or LSD can be a valuable tool for those struggling with anxiety and depression.
The study, recently published in Nature: Scientific Reports, demonstrated fewer symptoms of anxiety and depression, and greater feelings of wellbeing among individuals who reported consuming psychedelics in small quantities, or microdosing, compared to those who did not.
Microdosing involves regular self-administration of psychedelic substances in amounts small enough to not impair normal cognitive functioning.
Considering this is the largest psychedelic microdosing study published to date, the results are encouraging, says UBCO doctoral student and lead author Joseph Rootman.
Rootman works with Dr. Zach Walsh, a psychology professor in UBCO’s Irving K. Barber Faculty of Arts and Social Sciences. Dr. Walsh says it’s an exciting time for research in this area.
Read the full story here: UBC Okanagan News